Replies to post #3782 on Todos Med Ltd (TOMDF)

[Sukyamadda]

If you have been paying attention to the CEO, he has stated they will focus on marketing Tollovid around the holiday season. I think I get the logic behind that decision. If the results of Tollovir are successful, and 3CL protease inhibitors work, it is likely they will be able to market it as an OTC Covid treatment that has an active compound which is much more effective. The trade commission has warned them they cannot market it as such. While I dont believe we will get to $4, it is even more unlikely to do a r/s at $500.

[Gainzzz]

Adamantly disagree on most everything you said. What tough inquiries are you referring to? Also what sales request? If you are referring to getting an individual Cpass test, they have way bigger fish to fry than selling individual test to the general public. GC has stated this himself.

The product bottling?? Really?? My guess would be the one that says "Tollovid Daily" in huge font right on the front of the bottle would be the one you take daily.

[GREGG THE GREEK]

You have been spot on for a long time here.


#3782 RE: Gainzzz #3780
It's nice to dream but $4 without an R/S will never occur.

Remember, this is a company which 1) still does not have the ability, or desire, to answer any tough inquiries, 2 )doesn't even respond to sales requests, 3) has a CEO whom many don't trust, and 4)has almost a billion shares outstandingand 5) cant even bottle their products in a way where people can differentiate what they are attempting to purchase.

The possibilities for success are there for TODOS. It will come down to execution.

An R/S up to 1:500 is already approved and is inevitable.



Ridiculous, even back then, to believe that toDILUTIONos would ever get to $4 without an Rs.


And it's definitely not happening now.